E-LIB Suche - Ergebnisse für: von Moltke, Lisa

1

Preliminary Results of the Open-Label Phase of a 2-Part Pha..:

Ponce, Doris M. ; Kosuri, Satyajit ; Khera, Nandita...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S266 , 2024

Link: https://doi.org/10.1016/..

2

Sa1908 SAFETY AND EFFICACY OF FECAL MICROBIOTA SPORES, LIVE..:

Lashner, Bret ; von Moltke, Lisa ; De, Ananya.
Gastroenterology. 166 (2024) 5 - p. S-574 , 2024

Link: https://doi.org/10.1016/..

3

Integrated Safety and Efficacy Analyses of Phase 3 Trials o..:

Kraft, Colleen S. ; Sims, Matthew ; Silverman, Michael...
Infectious Diseases and Therapy. , 2024

Link: https://doi.org/10.1007/..

4

Integrated efficacy analysis from phase 3 studies of invest..:

Sims, Matthew ; Silverman, Michael ; Louie, Thomas...
Antimicrobial Stewardship & Healthcare Epidemiology. 3 (2023) S2 - p. s5-s5 , 2023

Link: https://doi.org/10.1017/..

5

Prevalence of Comorbid Factors in Patients With Recurrent C..:

Berenson, Charles S ; Lashner, Bret ; Korman, Louis Y...
Clinical Infectious Diseases. 77 (2023) 11 - p. 1504-1510 , 2023

Link: https://doi.org/10.1093/..

6

ENDOSCOPIC SCORE INTER-READER CONCORDANCE ANALYSIS FROM A P..:

Feagan, Brian ; Rubin, David ; Hanauer, Stephen...
Inflammatory Bowel Diseases. 29 (2023) Supplement_1 - p. S18-S19 , 2023

Link: https://doi.org/10.1093/..

7

ENDOSCOPIC SCORE INTER-READER CONCORDANCE ANALYSIS FROM A P..:

Feagan, Brian ; Rubin, David ; Hanauer, Stephen...
Gastroenterology. 164 (2023) 4 - p. S23-S24 , 2023

Link: https://doi.org/10.1053/..

8

Integrated safety analysis of phase 3 studies for investiga..:

Sims, Matthew ; Berenson, Charles ; Cohen, Stuart...
Antimicrobial Stewardship & Healthcare Epidemiology. 3 (2023) S2 - p. s44-s45 , 2023

Link: https://doi.org/10.1017/..

9

Su1873 RESULTS FROM AN OPEN-LABEL STUDY (ECOSPOR IV) TO EVA..:

Pardi, Darrell S. ; Oneto, Caterina ; Berenson, Charles...
Gastroenterology. 164 (2023) 6 - p. S-699-S-700 , 2023

Link: https://doi.org/10.1016/..

10

694 DURABILITY OF THE CLINICAL RESPONSE TO SER-109, AN INVE..:

Huang, Edward S. ; Lashner, Bret ; Sims, Matthew...
Gastroenterology. 164 (2023) 6 - p. S-140 , 2023

Link: https://doi.org/10.1016/..

11

Healthcare resource utilization in a phase 3 trial of SER-1..:

Cohen, Stuart ; Louie, Thomas ; Berenson, Charles...
Antimicrobial Stewardship & Healthcare Epidemiology. 2 (2022) S1 - p. s73-s73 , 2022

Link: https://doi.org/10.1017/..

12

Pharmacological profile of ALKS 7119, an investigational co..:

Dijkstra, Francis M. ; Zuiker, Rob G. J. A. ; Siebenga, Pieter S....
British Journal of Clinical Pharmacology. 88 (2022) 6 - p. 2909-2925 , 2022

Link: https://doi.org/10.1111/..

13

SER-109: An Oral Investigational Microbiome Therapeutic for..:

Khanna, Sahil ; Sims, Matthew ; Louie, Thomas J....
Antibiotics. 11 (2022) 9 - p. 1234 , 2022

Link: https://doi.org/10.3390/..

14

658. Diagnostic Testing Among Patients with Suspected Recur..:

Sims, Matthew ; Khanna, Sahil ; Pardi, Darrell...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S431-S431 , 2021

Link: https://doi.org/10.1093/..

15

639. Time to Recurrence of Clostridioides difficile Infecti..:

Louie, Thomas J ; Sims, Matthew ; Nathan, Richard...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S422-S422 , 2021

Link: https://doi.org/10.1093/..